Publication:
The efficacy and safety of anti-CD38 monoclonal antibodies in transplant-ineligible newly diagnosed multiple myeloma: systematic review and meta-analysis of randomized controlled trials

Simple item page
dc.contributor.coauthorAliyeva, T.
dc.contributor.coauthorShelar, V.
dc.contributor.coauthorKagizmanli, H.
dc.date.accessioned2026-08-14T11:27:24Z
dc.date.issued2025
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.versionPublished Version
dc.identifier.ScopusPercentile98
dc.identifier.ScopusQuartileQ1
dc.identifier.WoSPercentile99,2
dc.identifier.WoSQuartileQ1
dc.identifier.doi10.1016/j.annonc.2025.08.1924
dc.identifier.eissn1569-8041
dc.identifier.embargoN/A
dc.identifier.issn0923-7534
dc.identifier.urihttp://doi.org/10.1016/j.annonc.2025.08.1924
dc.identifier.urihttps://hdl.handle.net/20.500.14288/34657
dc.identifier.volume36
dc.identifier.wos001632551600127
dc.keywordsMonoclonal antibody
dc.keywordsMultiple myeloma
dc.keywordsRandomized controlled trial
dc.keywordsMonoclonal
dc.keywordsClinical trial
dc.languageeng
dc.publisherElsevier
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofAnnals of Oncology
dc.relation.openaccessN/A
dc.rightsN/A
dc.rights.uriN/A
dc.subjectHealth sciences
dc.subjectMedicine
dc.subjectHematology
dc.subjectOncology
dc.subjectGenetics
dc.titleThe efficacy and safety of anti-CD38 monoclonal antibodies in transplant-ineligible newly diagnosed multiple myeloma: systematic review and meta-analysis of randomized controlled trials
dc.typeMeeting Abstract
dspace.entity.typePublication

Files

Collections

Publications without Fulltext